Taiwanese Pharmaceuticals & Biotech Sustainable Track Record

Results

1 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

4 companies

PharmaEngine

Market Cap: NT$10.3b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

4162

NT$72.00

5.9%

-27.9%

Ever Supreme Bio Technology

Market Cap: NT$14.5b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

6712

NT$165.00

3.4%

4.0%

TTY Biopharm

Market Cap: NT$19.6b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

4105

NT$78.90

-0.5%

8.4%

Bora Pharmaceuticals

Market Cap: NT$70.5b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

6472

NT$568.00

-8.7%

-11.5%